119 S2693 IS: Biobased Market Expansion Act of 2025
U.S. Senate
2025-09-03
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
II
119th CONGRESS
1st Session
S. 2693
IN THE SENATE OF THE UNITED STATES
September 3, 2025
Mr. Young (for himself and Mr. Padilla) introduced the following bill; which was read twice and referred to the Committee on Agriculture, Nutrition, and Forestry
A BILL
To amend the Farm Security and Rural Investment Act of 2002 to enhance the recognition, procurement, and domestic production of biobased products, and for other purposes.
1.

Short title
This Act may be cited as the “Biobased Market Expansion Act of 2025”.
2.

Expansion of the biobased markets program
Section 9002 of the Farm Security and Rural Investment Act of 2002 (7 U.S.C. 8102) is amended—
(1)
in subsection (a)—
(A)
in paragraph (2)—
(i)
in subparagraph (A)(i)—
(I)
in subclause (II)(bb), by striking “and” at the end;
(II)
in subclause (III), by striking the period at the end and inserting “; and”; and
(III)
by adding at the end the following:
“(IV)
on an annual basis, update the procurement requirement established under subclause (III) by increasing the number of biobased-only contracts or the volume purchased under those contracts from the previous year.”; and
(ii)
in subparagraph (B)—
(I)
in clause (ii)(II), by striking “or” at the end; and
(II)
by striking clause (iii) and inserting the following:
“(iii)
are available only at a price that exceeds the price preference established under paragraph (3)(B)(ix) for those items; or
(iv)
do not meet procurement requirements under chapter 83 of title 41, United States Code (commonly known as the “Buy American Act”).”;
(B)
in paragraph (3)—
(i)
in subparagraph (B)—
(I)
in clause (vii), by striking “and” at the end;
(II)
by redesignating clause (viii) as clause (x); and
(III)
by inserting after clause (vii) the following:
“(viii)
promote biobased products that are produced wholly or in part in the United States;
(ix)
establish price preferences for biobased products; and”; and
(ii)
in subparagraph (E), by striking “which—” in the matter preceding clause (i) and all that follows through “the quantity” in clause (ii) and inserting “which the quantity”; and
(C)
in paragraph (4)—
(i)
in subparagraph (A)—
(I)
by striking clause (ii);
(II)
by redesignating clauses (iii) and (iv) as clauses (ii) and (iii), respectively; and
(III)
in clause (iii) (as so redesignated)—
- (aa)
in the matter preceding subclause (I), by inserting “and publish on a publicly available website” after “Congress”;
- (bb)
in subclause (I), by striking “and” at the end;
- (cc)
in subclause (II), by striking the period at the end and inserting “; and”; and
- (dd)
by adding at the end the following:
“(III)
outlines any potential barriers to compliance by procuring agencies.”;
(ii)
in subparagraph (B)(i)—
(I)
in each of subclauses (IV) and (V), by striking “and” at the end; and
(II)
by adding at the end the following:
“(VI)
if applicable, the procurement requirement established under paragraph (2)(A)(i) that the procuring agency failed to meet and reasons for the failure; and
(VII)
the specific categories, performance standards, and other specifications of products for which biobased products are commercially unavailable to meet the needs of the procuring agency; and”; and
(iii)
by adding at the end the following:
“(D)

Training
Not later than 2 years after the date of enactment of this subparagraph, each procuring agency shall ensure that contracting officers, purchase card managers, purchase card holders, and other appropriate staff have completed training on and have begun to implement biobased product purchasing.
(E)

Federal catalog
Not later than 2 years after the date of enactment of this subparagraph, the Administrator of General Services, in cooperation with the Secretary, shall update Federal catalogs and data systems for procurement and contracting to clearly delineate eligible biobased products.
(F)

Verification
The Office of Federal Procurement Policy shall—
(i)
annually collect, and make publicly available, the information required to be reported under subparagraph (B); and
(ii)
annually verify, using the information collected under subparagraph (B), that each procuring agency, as applicable, has established and is operating a procurement program in accordance with under paragraph (2)(A)(i)(I).”;
(2)
in subsection (b)(2)(B)—
(A)
in clause (ii), by striking “and” at the end;
(B)
in clause (iii), by striking the period at the end and inserting “; and”; and
(C)
by adding at the end the following:
“(iv)
encourage the purchase of biobased products that are produced wholly or in part within the United States.”;
(3)
in subsection (j)(3)—
(A)
in subparagraph (A), by striking clauses (iv) and (v) and inserting the following:
“(iv)
the estimated economic value returned to the agricultural industry;
(v)
the geographic distribution and value of biomanufacturing facilities or biorefineries producing products bearing the label described in subsection (b)(1); and”; and
(B)
in subparagraph (B), strike “this subparagraph” and inserting “the Biobased Market Expansion Act of 2025”; and
(4)
by adding at the end the following:
“(n)

Review
Not later than 2 years after the date of enactment of the Biobased Market Expansion Act of 2025, the Comptroller General of the United States shall submit to Congress a report that describes—
(1)
an assessment of the implementation of this section, including—
(A)
the compliance of procuring agencies with subsection (a)(2);
(B)
the efficacy of guidelines developed under subsection (a)(3);
(C)
compliance with requirements under subsection (a)(4); and
(D)
the recognition programs developed under subsection (c);
(2)
a review of data provided by procuring agencies to determine whether the data being collected is adequate and actionable for policymakers to make decisions regarding the implementation of this section;
(3)
recommendations for additional data needed for procuring agencies to increase biobased procurement;
(4)
recommendations for improvements to the biobased procurement programs of the Department of Agriculture; and
(5)
opportunities to improve procurement of biobased products made in the United States.”.